News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Your AI-Trained Oncology Knowledge Connection!

Christopher R D'Angelo, MD

Articles by Christopher R D'Angelo, MD

7 experts are featured in this series.

Clinical Scenario: Treatment Decisions for a 53-Year-Old w/ R/R LBCL

ByMatthew A. Lunning, DO,Loretta J. Nastoupil, MD,Brian T. Hill, MD, PhD,Christopher R D'Angelo, MD,David Miklos, MD, PhD,Nathan Denlinger, DO, MS ,Amitkumar Mehta, MD

January 22nd 2026

7 experts are featured in this series.

Clinical Scenario: Treatment Decisions for a 31-Year-Old w/ R/R LBCL

ByMatthew A. Lunning, DO,Loretta J. Nastoupil, MD,Brian T. Hill, MD, PhD,Christopher R D'Angelo, MD,David Miklos, MD, PhD,Nathan Denlinger, DO, MS ,Amitkumar Mehta, MD

January 22nd 2026

7 experts are featured in this series.

Optimizing CAR T-Cell Access & Delivery in R/R LBCL

ByMatthew A. Lunning, DO,Loretta J. Nastoupil, MD,Brian T. Hill, MD, PhD,Christopher R D'Angelo, MD,David Miklos, MD, PhD,Nathan Denlinger, DO, MS ,Amitkumar Mehta, MD

January 15th 2026

7 experts are featured in this series.

Navigating 2L Treatment Pathways in LBCL

ByMatthew A. Lunning, DO,Loretta J. Nastoupil, MD,Brian T. Hill, MD, PhD,Christopher R D'Angelo, MD,David Miklos, MD, PhD,Nathan Denlinger, DO, MS ,Amitkumar Mehta, MD

January 15th 2026

7 experts are featured in this series.

CAR T Outcomes in LBCL: US Flatiron EMR Real-World Findings

ByMatthew A. Lunning, DO,Loretta J. Nastoupil, MD,Brian T. Hill, MD, PhD,Christopher R D'Angelo, MD,David Miklos, MD, PhD,Nathan Denlinger, DO, MS ,Amitkumar Mehta, MD

January 8th 2026

7 experts are featured in this series.

Real-World Treatment Patterns in R/R LBCL: Insights from Flatiron Data Pre & Post 2L CAR T Approval

ByMatthew A. Lunning, DO,Loretta J. Nastoupil, MD,Brian T. Hill, MD, PhD,Christopher R D'Angelo, MD,David Miklos, MD, PhD,Nathan Denlinger, DO, MS ,Amitkumar Mehta, MD

January 8th 2026

7 experts are featured in this series.

ZUMA-7 Final Analysis: Key Efficacy and Safety Findings

ByMatthew A. Lunning, DO,Loretta J. Nastoupil, MD,Brian T. Hill, MD, PhD,Christopher R D'Angelo, MD,David Miklos, MD, PhD,Nathan Denlinger, DO, MS ,Amitkumar Mehta, MD

December 19th 2025

7 experts are featured in this series.

TRANSFORM + Long-Term Follow-Up ASH 2025 Insights: Durability, Survival, and Safety Updates

ByMatthew A. Lunning, DO,Loretta J. Nastoupil, MD,Brian T. Hill, MD, PhD,Christopher R D'Angelo, MD,David Miklos, MD, PhD,Nathan Denlinger, DO, MS ,Amitkumar Mehta, MD

December 19th 2025

Latest Updated Articles

ZUMA-7 Final Analysis: Key Efficacy and Safety Findings
Published: December 19th 2025 | Updated:
CAR T Outcomes in LBCL: US Flatiron EMR Real-World Findings
Published: January 8th 2026 | Updated:

Trending on CancerNetwork

TLD-1433 Exhibits Early Efficacy in BCG-Unresponsive NMIBC CIS

Dato-DXd Receives Priority Review in Unresectable/Metastatic TNBC

FDA Accepts NDA for Rivoceranib and Camrelizumab in 1L Unresectable HCC

FDA Grants Fast Track Designation to Pelareorep in KRAS+ MSS Metastatic CRC

Maximizing Control Via Radiation in High-Risk and Recurrent Breast Cancer